Telomir Pharmaceuticals, Inc. (TELO) Cash flow

208 Followers

Telomir Pharmaceuticals, Inc. Cash Flow

TELO's free cash flow for Q4 2025 was $-1.20M. For the 2025 fiscal year, TELO's free cash flow was decreased by $1.38M and operating cash flow was $-1.20M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -3.69M	$ -5.07M	$ -3.86M	$ -468.66K	$ -119.40K
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 9.71M	$ 6.34M	$ 3.86M	$ 470.08K	$ 119.40K
End Cash Position	$ 7.29M	$ 1.27M	$ 1.23K	$ 1.42K	$ 0.00
Free Cash Flow	$ -3.69M	$ -5.07M	$ -3.86M	$ -468.66K	$ -119.40K

Currency in USD